ID   FL-SJC
AC   CVCL_ZU78
DR   cancercelllines; CVCL_ZU78
DR   Wikidata; Q98126239
RX   PubMed=32459397;
CC   Population: Chinese.
CC   Doubling time: 24 hours (PubMed=32459397).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=32459397).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=32459397).
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Ser1680del (c.5036_5038CCT[1]) (c.5039_5041delCCT) (p.Ser1642del, c.4922_4924CCT[1]); ClinVar=VCV000158384; Zygosity=Unspecified (PubMed=32459397).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Met1379Valfs*52 (c.4135_4136delAT); ClinVar=VCV000094216; Zygosity=Unspecified (PubMed=32459397).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C125904; High grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements
DI   ORDO; Orphanet_480541; High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
RX   PubMed=32459397; DOI=10.1111/jcmm.15425; PMCID=PMC7348184;
RA   Chen M., Jiang G.-X., Liu Y.-C., Li D.-Y., Li T.-T., Peng J., Jiang Q.,
RA   You H.-Y., Ba R., Pan J.-L., Li M., Long W.-G., Yan J.-S., Zhu Y.,
RA   Wang Y., Xi X.-D., Mao J.-H., Shi X.-F.;
RT   "Establishment and characterization of a novel 'double-hit' follicular
RT   lymphoma cell line, FL-SJC.";
RL   J. Cell. Mol. Med. 24:7928-7938(2020).
//